It is important in life to learn to do the unpleasant things; to take on the difficult tasks. So it is with a heavy heart that I summarize a report on investing in digital health. So many buzz words, so little time. (SUH Report) The single most frightening piece of information in the report is the estimate of 7500 companies worldwide working on digital health. On the other hand, lots of material for my Headlines. The first quarter of 2015 saw $900 million invested in digital health, compared to $1.5 billion in the year-ago quarter. (Is sanity returning?) The top ten investments by size accounted for 45% of all investing. The largest category was “big data/analytics”, with $202 million in 6 transactions. (No, it’s not.) Then came wellness, $137 million in 10 deals; patient experience, $107 million in 20 investments; and medical device/diagnostics, $106 million in 11 deals. Geographically, the Bay Area led with $390 million in 25 financings, followed by San Diego with $127 million in 4 transactions. Boston, Salt Lake City and NYC companies also drew a fair amount of investment. Slightly more money went to investments after the seed investment, as the industry begins to “mature”. The median size for an early-stage investment also declined, while later stage amounts rose somewhat. Corporate venture groups were active, along with the usual vc suspects. One area of focus continues to be companies aiming at older Americans, the 50-plus crowd, with about 40% of funding in the first quarter going to companies targeting this segment, many with products and services to manage chronic diseases. And while I love to mock and ridicule the hype that often surrounds emerging companies and sectors, all this investment provides a lot of good jobs, at least for some time, and a few might provide a return to investors. One or two might even develop a product that actually improves people’s health status or the care they receive.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
A Review of the Federal Government’s CV-19 Response
November 1, 2024
A Review of the Federal Government’s CV-19 Response
A US House Committee notes the obvious--the federal government's response to the epidemic was flawed…
Commentary
Ouch, the Jobs Numbers Continue to Unwind
November 1, 2024
Ouch, the Jobs Numbers Continue to Unwind
The official jobs report for October is a big surprise to the downside, with reductions…
Commentary
Climate Models Are Worthless
October 31, 2024
Climate Models Are Worthless
A key parameter in climate models is off by 30%, according to new research. Which…